Menora Mivtachim Holdings Invests in Alexandria Real Estate Equities

Institutional investor buys 735,000 shares of real estate investment trust

Mar. 13, 2026 at 10:52am

Menora Mivtachim Holdings LTD., an institutional investor, has purchased a new position of 735,000 shares in Alexandria Real Estate Equities, Inc. (NYSE:ARE), a real estate investment trust that specializes in collaborative life science and technology campuses. The transaction, valued at approximately $61.3 million, represents around 0.43% ownership of Alexandria Real Estate Equities.

Why it matters

This investment by Menora Mivtachim Holdings, a prominent institutional investor, signals confidence in the long-term growth potential of Alexandria Real Estate Equities. As a leading REIT in the life science and technology real estate sector, Alexandria's properties are designed to support innovation and research, making it an attractive investment for those bullish on the life sciences industry.

The details

According to a recent 13F filing with the Securities and Exchange Commission, Menora Mivtachim Holdings acquired the 735,000 shares of Alexandria Real Estate Equities in the third quarter. This new position represents approximately 0.43% of the REIT's outstanding shares.

  • Menora Mivtachim Holdings purchased the 735,000 shares of Alexandria Real Estate Equities in the third quarter.

The players

Menora Mivtachim Holdings LTD.

An institutional investor that has purchased a new position in shares of Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc.

A real estate investment trust that specializes in the ownership, development, and management of collaborative life science and technology campuses.

Got photos? Submit your photos here. ›

The takeaway

This investment by Menora Mivtachim Holdings underscores the continued investor interest in the life sciences real estate sector, which has seen strong demand driven by the growth of the biotechnology and pharmaceutical industries. Alexandria's specialized properties and focus on innovation hubs make it an appealing option for institutional investors seeking exposure to this dynamic market.